Rapid access treatment pathway for patients with severe symptomatic heart valve disease

British Heart Valve Society

The British Heart Valve Society calls for a rapid access treatment pathway for severe symptomatic heart valve disease with a referral-to-treatment target of 8 weeks to ensure timely access to effective valve intervention within the NHS for better patient outcomes.  (more…)

A look at Rheumatic Heart Valve Disease

By Dr Sally Chapman Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) remain a worldwide health problem, causing premature morbidity and mortality. The highest rates of ARF and RHD are seen in developing countries, particularly Central and sub- Saharan Africa. This is largely due to poor economic status, overcrowding of homes and limited (more…)